oxybutynin has been researched along with Erythema in 8 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
Excerpt | Relevance | Reference |
---|---|---|
"Using Medline, Embase, and the Science Citation Index, we summarize the cutaneous adverse effects of transdermal and parenteral fentanyl." | 2.46 | Fentanyl transdermal patches: overview of cutaneous adverse effects in humans. ( Hostynek, JJ; Maibach, HI, 2010) |
"Localized neuropathic pain (LNP) is a subgroup of neuropathic pain characterized by consistent and circumscribed area(s) of maximum pain, associated with negative or positive sensory signs and/or spontaneous symptoms characteristic of NP." | 1.48 | Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy. ( Chinellato, E; Del Balzo, G; Martini, A; Parolini, M; Picelli, A; Polati, E; Schweiger, V; Tamburin, S; Zanzotti, M, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Chancellor, M | 1 |
Ruan, J | 1 |
Liu, C | 1 |
Wang, J | 1 |
Zhong, T | 1 |
Quan, P | 1 |
Fang, L | 1 |
Park, JH | 2 |
Kim, CB | 1 |
Lee, HJ | 1 |
Roh, JY | 1 |
Lee, JM | 1 |
Kim, HJ | 1 |
Muller, DA | 1 |
Henricson, J | 1 |
Baker, SB | 1 |
Togö, T | 1 |
Jayashi Flores, CM | 1 |
Lemaire, PA | 1 |
Forster, A | 1 |
Anderson, CD | 1 |
Martini, A | 1 |
Del Balzo, G | 1 |
Schweiger, V | 1 |
Zanzotti, M | 1 |
Picelli, A | 1 |
Parolini, M | 1 |
Chinellato, E | 1 |
Tamburin, S | 1 |
Polati, E | 1 |
Bermejo, PE | 1 |
Zea, MA | 1 |
Alba-Alcántara, L | 1 |
Ruiz-Huete, C | 1 |
Hostynek, JJ | 1 |
Maibach, HI | 1 |
HOLLE, F | 1 |
1 review available for oxybutynin and Erythema
Article | Year |
---|---|
Fentanyl transdermal patches: overview of cutaneous adverse effects in humans.
Topics: Analgesics, Opioid; Dermatitis, Allergic Contact; Dermatitis, Irritant; Erythema; Female; Fentanyl; | 2010 |
1 trial available for oxybutynin and Erythema
Article | Year |
---|---|
Innate local response and tissue recovery following application of high density microarray patches to human skin.
Topics: Adolescent; Adult; Aged; Epidermis; Erythema; Humans; Male; Middle Aged; Transdermal Patch; Vaccinat | 2020 |
6 other studies available for oxybutynin and Erythema
Article | Year |
---|---|
Transdermal oxybutynin. A viewpoint by Michael Chancellor.
Topics: Administration, Cutaneous; Delayed-Action Preparations; Erythema; Humans; Mandelic Acids; Pruritus; | 2003 |
Efficacy and safety of permeation enhancers: A kinetic evaluation approach and molecular mechanism study in the skin.
Topics: Administration, Cutaneous; Erythema; Humans; Permeability; Skin; Skin Absorption; Transdermal Patch | 2022 |
Development and clinical study of the use of infrared radiation to accelerate the dissolution rate of a microneedle array patch (MAP).
Topics: Adult; Erythema; Female; Humans; Hyaluronic Acid; Infrared Rays; Male; Microinjections; Solubility; | 2020 |
Efficacy of lidocaine 5% medicated plaster (VERSATIS®) in patients with localized neuropathic pain poorly responsive to pharmacological therapy.
Topics: Aged; Analgesics; Anesthetics, Local; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; E | 2018 |
[Local effects of transdermal treatment with rotigotine].
Topics: Aged; Antiparkinson Agents; Dopamine Agonists; Drug Evaluation; Drug Therapy, Combination; Equipment | 2013 |
[Patch ultraviolet irradiation as demonstration of effective desympathization].
Topics: Erythema; Humans; Transdermal Patch; Ultraviolet Rays; Ultraviolet Therapy | 1954 |